Background Myostatin is a negative regulator of skeletal muscle mass. On the other hand,
growth differentiation factor (GDF)-15 is associated with lower muscle strength and muscle …

Background: Cardiovascular diseases (CVD) continue to threaten health worldwide, and
account for a significant portion of deaths and illnesses. In both developing and …

Background The lack of physical activity is a common issue in modern society and is
considered a major risk factor for various chronic non-communicable diseases. Bioactive …

The prevalence of sarcopenia (loss of muscle strength, mass and function) in individuals
with heart failure (HF) stands at a considerable level (approximately 20%), contributing to …

The triad of vascular impairment, muscle atrophy, and cognitive decline represents critical
age-related conditions that significantly impact health. Vascular impairment disrupts blood …

Cardiovascular disease (CVD) incidence is high in patients with chronic kidney disease
(CKD) and is the most frequent cause of mortality in this population. Advanced age …

Background Sarcopenia, which is evaluated based on appendicular skeletal muscle mass
(ASM) using dual-energy X-ray absorptiometry and bioelectrical impedance analysis, is a …

Objetivo Determinar la relación entre los niveles actividad física (AF) y la condición física
(CF) autopercibida en una muestra de estudiantes universitarios en Bogotá, Colombia …

Background Cardiometabolic multimorbidity (CM) is emerging as a global health challenge.
This study investigated the potential impact of muscle strength on the risk of CM in middle …

Background Sarcopenia is associated with oxidative stress. The Oxidative Balance Score
(OBS) is commonly used to assess dietary and lifestyle exposure to oxidative stress …